Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-22-008105
Filing Date
2022-03-01
Accepted
2022-03-01 17:12:46
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5.htm 424B5 1047184
2 EX-FILING FEES xene-exfilingfees_177.htm EX-FILING FEES 81462
3 GRAPHIC gyu1yhw1mz2i000003.jpg GRAPHIC 10332
4 GRAPHIC gyu1yhw1mz2i000001.jpg GRAPHIC 10332
5 GRAPHIC gyu1yhw1mz2i000002.jpg GRAPHIC 7563
  Complete submission text file 0001564590-22-008105.txt   1168932
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260010 | Film No.: 22699614
SIC: 2834 Pharmaceutical Preparations